Literature DB >> 565391

Increased platelet serotonin in bipolar depression and hypomania.

A Wirz-Justice, W Pühringer.   

Abstract

Platelet serotonin (5-HT) was higher at 8 a.m. in untreated bipolar depressives than in controls. This high 5-HT was different from unipolar depressives where 5-HT levels were similar to controls but showed altered diurnal rhythmicity. Further differences between unipolar and bipolar patients were found. 5-HT levels and 5-HT uptake into platelets were not correlated in bipolar depressives as found in both unipolar depressives and controls; and 5-HT levels and platelet monoamineoxidase activity tended to be negatively correlated in bipolar but not in unipolar depressives and controls. A longitudinal study of a bipolar II patient throughout three hospitalizations for depression followed by the switch into hypomania, indicated that 5-HT was state independent, remaining constantly high in all clinical conditions and upon remission, reduced only during and after treatment with clomipramine, a 5-HT uptakt dysfunction of indoleamines underlying bipolar illness.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 565391     DOI: 10.1007/bf01262729

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  15 in total

1.  Reduced central serotonergic activity in mania: implications for the relationship between depression and mania.

Authors:  J Mendels; A Frazer
Journal:  Br J Psychiatry       Date:  1975-03       Impact factor: 9.319

2.  L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders.

Authors:  A J Prange; I C Wilson; C W Lynn; L B Alltop; R A Stikeleather
Journal:  Arch Gen Psychiatry       Date:  1974-01

3.  Manic states. A genetic study of early and late onset affective disorders.

Authors:  M Taylor; R Abrams
Journal:  Arch Gen Psychiatry       Date:  1973-05

4.  Abnormalities of indoleamines in affective disorders.

Authors:  A Coppen; A J Prange; P C Whybrow; R Noguera
Journal:  Arch Gen Psychiatry       Date:  1972-05

5.  Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients.

Authors:  D L Murphy; R Weiss
Journal:  Am J Psychiatry       Date:  1972-05       Impact factor: 18.112

6.  The level and diurnal rhythm of serum serotonin in manic-depressive patients.

Authors:  K Sarai; M Kayano
Journal:  Folia Psychiatr Neurol Jpn       Date:  1968

7.  Intravenous L-5-hydroxytryptophan in normal subjects: an interdisciplinary precursor loading study. Part III: Neuroendocrinological and biochemical changes.

Authors:  A Wirz-Justice; W Pühringer; V Lacoste; P Graw; M Gastpar
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1976-11

8.  [L-5-hydroxytryptophan(L-5-HTP) therapy in endogenous depression. 1].

Authors:  I Sano
Journal:  Munch Med Wochenschr       Date:  1972-10-06

9.  Diurnal and seasonal variations in human platelet serotonin in man.

Authors:  A Wirz-Justice; M Lichtsteiner; H Feer
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

10.  Seasonal incidence of an altered diurnal rhythm of platelet serotonin in unipolar depression.

Authors:  A Wirz-Justice; W Pühringer
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

View more
  4 in total

Review 1.  Platelet research in psychiatry.

Authors:  A Wirz-Justice
Journal:  Experientia       Date:  1988-02-15

2.  Increased uptake of serotonin by blood platelets from patients with bipolar primary affective disorder-bipolar type.

Authors:  Z Zemishlany; H Munitz; A Rotman; H Wijsenbeek
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  Blood noradrenaline and 5-HT levels in depressed women during amitriptyline or lithium treatment.

Authors:  G L Corona; M L Cucchi; G Santagostino; P Frattini; F Zerbi; L Fenoglio; F Savoldi
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Changes in human platelet 5 HT level after 1 week of chlorimipramine treatment.

Authors:  M F Poirier; K H Le Quan-Bui; H Lôo; P Meyer
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.